Document is current
Any future updates will be listed below
-
Authors
Elsässer, Franziska https://orcid.org/0000-0002-0830-3941
Florea, Roberta https://orcid.org/0009-0002-2716-1560
Räsch, Felix
Zedan, Mostafa https://orcid.org/0009-0006-9712-3315
Sen, Nesli-Ece
Pflästerer, Tim
Kleele, Tatjana https://orcid.org/0000-0001-5320-7337
Loewith, Robbie https://orcid.org/0000-0002-2482-603X
Weis, Karsten https://orcid.org/0000-0001-7224-925X
de Souza, Natalie https://orcid.org/0000-0003-4286-8951
Picotti, Paola https://orcid.org/0000-0002-4109-3552
-
Funding
Funding for this research was provided by:
EC | ERC | HORIZON EUROPE European Research Council (866004)
European Proteomics Infrastructure Consortium providing access (823839)
National Center of Competence in Research AntiResist (51NF40_180541)
National Center of Competence in Research AntiResist (TMAG-3_209354)
- License Information
-
More Information
Article History
Received: 7 April 2025
Revised: 24 November 2025
Accepted: 11 December 2025
First Online: 12 January 2026
Disclosure and competing interests statement
: PP is a scientific advisor for the company Biognosys AG (Zurich, Switzerland) and an inventor of a patent licensed by Biognosys AG that covers the LiP-MS method used in this work. FE, RF, and PP have filed a patent application based on this work (European Patent Application No. 23197690). The remaining authors declare no competing interests.
